Loading…
Attending this event?
Wednesday, June 19 • 3:15pm - 4:15pm
#369: Improving Communication Across Differences in Drug Development Teams

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Workshop
Level: Intermediate

The interactive workshop will provide an opportunity for participants to discuss common barriers that hinder effective communication in cross-cultural, diverse teams. Discussion will draw from the management, psychology, and drug development literature to help contextualize communication and feedback giving.

Learning Objectives

Identify and discuss common interactions and patterns that can hinder effective communication in diverse and cross-cultural teams in drug development; Describe common pitfalls and fallacies related to feedback and learn how to avoid them; Identify evidence-based solutions on how to reduce barriers to communication.

Chair

Jennifer Kim, PhD

Speaker

Empirical Perspective: What the Research on Team Communication in Drug Development Reveals
Emily Botto

Learning and Development Perspective: Best Practices for Training and Implementation
Tamei Elliott, MS

Case Perspective: Learnings from the Field
Christine Mayer-Nicolai, PharmD


Speakers
avatar for Jennifer Kim

Jennifer Kim

Research Assistant Professor, Tufts Center for the Study of Drug Development, United States
I'm a Research Assistant Professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine. My research focuses on health and work equity, examining how diversity, equity and inclusion dynamics impact individual, group, and organizational outcomes... Read More →
avatar for Emily Botto

Emily Botto

Research Analyst, Tufts Center for the Study of Drug Development, United States
Emily Botto joined the Tufts Center for the Study of Drug Development (Tufts CSDD) as a Research Analyst in October 2020 after graduating from Brandeis University. Her work focuses on studies relating to clinical research execution strategies and practices as well as clinical trial... Read More →
avatar for Tamei Elliott

Tamei Elliott

Associate Director, Scientific Programs, DIA, United States
Tamei Elliott, MS, serves as the Associate Director of Scientific Programs for the Americas region at DIA. In this pivotal role, she is responsible for identifying and prioritizing content areas and topics crucial to DIA constituents. Tamei assesses the implications of significant... Read More →
avatar for Christine Mayer-Nicolai

Christine Mayer-Nicolai

Vice President, Regulatory and Scientific Policy, Merck Healtcare KGaA, Germany
Dr. Christine Mayer-Nicolai, VP, Regulatory & Scientific Policy at Merck Healthcare KGaA, Germany is based in Darmstadt and Washington, DC. She is leading the development of Merck Healthcare regulatory policy priorities, identifying, and responding to global regulatory and legislative... Read More →

Wednesday June 19, 2024 3:15pm - 4:15pm PDT
Room 8 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  13: ProfDevelopment, Workshop